About Annogen
Leading in tailored gene expression for safer, more effective therapies.
Annogen was founded in 2017 by Dr. Joris van Arensbergen, as a spin-out of the world-renowned Netherlands Cancer Institute (NKI).
Today, Annogen is an independent company and the trusted partner of leading biopharmaceutical, agricultural and academic research centers for bespoke gene expression engineering.
Our Vision
At Annogen, we believe in a future where advanced therapies are precisely and durably treating diseased tissues, eliminating unintended side effects. We believe that optimizing gene expression is a crucial step to achieving this goal.
Our mission is to become an expertise hub for gene expression engineering, serving as the preferred partner for leading biopharmaceutical, agricultural and academic research centers.
Joris van Arensbergen, PhD
Founder & CEO
Martijn Kelder, PhD
Chief Strategy Officer
Alexey Pindyurin, PhD
Senior Scientist
Christiane Llaca, BBA
Operations Manager
Daan Peric-Hupkes, PhD
Senior Scientist & Biological Safety Officer
Jihed Chouaref, PhD
Bioinformatics Scientist
Ludo Pagie, PhD
Senior Bioinformatics Scientist
Michelle van Heck
Senior Technician
Miriam Smits, BSc
Senior Technician
Naomi Duncan
Intern
Tijn van Balen, BSc
Junior Scientist
Careers
Work in a close-knit, diverse team focused on delivering top-notch scientific advancements with real-life applications, while maintaining a healthy work-life balance.
Vacancies are shown below, while we also accept open applications on [email protected], requiring a motivation letter and C.V.
We gladly accept internship applications from students enrolled in a relevant academic program with at least 3 months of previous research experience, for a minimum internship period of 9 months for wet-lab work and for a minimum of 6 months for bioinformatics projects.
Vacancy: Bioinformatician (32-40hrs)
Contact
Have questions or want to learn more about how Annogen can partner with you in advancing your genetic engineering? Let’s hear from you!
“Annogen’s commitment to daring, innovative and challenging science is what drew me to the company.”
Tijn van Balen, Junior Scientist
